• Patient Action Center
  • Seniors Rising Now
0 Items
Patients Rising Now
  • Home
  • About
    • About Us
    • Who We Are
    • Partners and Coalitions
    • Corporate Membership
    • Corporate Members
    • Financials
  • Issues
    • 117th Congress Advocacy Scorecard
    • Legislative Positions
    • Terry’s Hot Take
    • News and Insights
    • Positions
    • Policy Supported
  • Take Action
    • Patient Action Center
    • What You Can Do
    • Advocacy Masterclass
  • Donate
Select Page
  • Home
  • About
    • About Us
    • Who We Are
    • Partners and Coalitions
    • Corporate Membership
    • Corporate Members
    • Financials
  • Issues
    • 117th Congress Advocacy Scorecard
    • Legislative Positions
    • Terry’s Hot Take
    • News and Insights
    • Positions
    • Policy Supported
  • Take Action
    • Patient Action Center
    • What You Can Do
    • Advocacy Masterclass
  • Donate

Health Policy

Patients Rising Now Releases “What You Don’t Know About the Reconciliation Bill”

Patients Rising Now Releases “What You Don’t Know About the Reconciliation Bill”

Aug 5, 2022 | Featured, Health Policy

WASHINGTON — Patients Rising NOW today released “What You Don’t Know About the Reconciliation Bill,” the organization’s fact-check of the drug pricing provisions within the Senate’s reconciliation bill, or the 725-page Inflation Reduction Act of 2022.  The list...
Read more
REFUND Act: Claiming a Discarded Drug Rebate from Pharma

REFUND Act: Claiming a Discarded Drug Rebate from Pharma

Jul 25, 2022 | Featured, Health Policy

By Surabhi Dangi-Garimella, PhD Injectable drugs, which are usually manufactured as single-dose vials, are administered by health care providers based on a person’s body weight. Variability in body weight means there is medication left over in the vial, which has to...
Read more
OIG Report Tags Biosimilars for Medicare and Beneficiary Savings

OIG Report Tags Biosimilars for Medicare and Beneficiary Savings

May 13, 2022 | Featured, Health Policy

Surabhi Dangi-Garimella, Ph.D. Despite biosimilars being around for a while, utilization in the U.S. has not caught on. Several studies have shown the cost benefit of replacing originator or reference products with biosimilars; however, contracts between drug...
Read more
Season 3: Episode 11: Congress’ Healthcare Showdown

Season 3: Episode 11: Congress’ Healthcare Showdown

Mar 21, 2022 | Featured, Health Policy

On this episode of the podcast, Terry and Bob discuss the healthcare bills Congress is currently considering and what they mean for patients. They break down the D.C. lingo and highlight three healthcare bills that will shape access to care and elevate patient voices:...
Read more
S3 | E6 Making Sense of California’s Healthcare News

S3 | E6 Making Sense of California’s Healthcare News

Feb 14, 2022 | Featured, Health Insurance, Health Policy

Season 3 | Episode 6: Making Sense of California’s Healthcare News On this episode of the podcast, Terry and Bob discuss the bid for universal healthcare in California. They also talk about the latest health policy developments at the federal level, including...
Read more
Right to Repair: A Catch-22 for Patient Health

Right to Repair: A Catch-22 for Patient Health

Jan 31, 2022 | Federal Issues, Health Policy

By Surabhi Dangi-Garimella, Ph.D.  Repair restrictions by equipment manufacturers remains a significant issue that spans industries and is relevant to consumer protection and antitrust issues related to repair restrictions—be it phone or car manufacturers or...
Read more
« Older Entries

Categories

  • Access
  • Advocacy
  • California
  • Comment Letters
  • Copay Accumulators
  • Copay Assistance
  • COVID-19
  • Drug Costs
  • FDA
  • Featured
  • Featured Action
  • Federal Issues
  • Health Insurance
  • Health Policy
  • ICER
  • Illinois
  • Issues
  • Letters Submitted
  • Letters Supported
  • Massachusetts
  • Medicaid
  • Medicare
  • Medicare Part D
  • News
  • Op-Ed
  • Out of Pocket Costs
  • Pharmacy Benefit Managers
  • Podcast
  • Prescription Drugs
  • Press Releases
  • Public Statement
  • QALY
  • State Issues
  • Statements
  • Step Therapy
  • Surprise Billing
  • Terry's Hot Take
  • Uncategorized
  • Value Based Insurance Design
  • Value Frameworks
  • Virtual Advocacy Chat

Tags

21st Century Cures Act 340B Access to Care Advocacy Alzheimer's Biden Administration biosimilars Cancer cms Copay Accumulators copay assistance COVID-19 Vaccine drug costs Drug Manufacturing Drug Pricing drug rebate fail first FDA Gene Therapies H.R.3 Health Insurance hospital bills HR 3708 hsa ICER Insurance design Joe Biden medicare Part B medicare part D Mental Health Nonmedical Switching open enrollment Out of Pocket Costs PBM PBMs pharmacy benefit managers Price Transparency Prior Authorization QALY Rare Disease Right to Repair Step Therapy Telehealth transparency Value Framework

Recent Posts

  • Rural Hospital Closures Further Complicates Healthcare Access in Mississippi
  • Contract Changes Leave DoD TRICARE Beneficiaries Without Pharmacy Access
  • Most Popular Podcast Episodes in 2022 From Patients Rising
  • Patients Rising Now Signs onto Letter to President on Alzheimer’s Scans
  • PRN and 17 Patient Groups Send Letter to Hill on Home Health Cuts

Get Updates In Your Inbox

Sign up for updates about our patient education, support and advocacy programs and initiatives.

YES, KEEP ME UPDATED

Patients Rising Now

We are a 501c4 group dedicated to demanding transparency in health care.  We are part of the Patients Rising suite of programs and services.

700 12th St. NW 700, Suite 700
Washington, DC 20005
202-679-8223

 

  • Privacy Policy
  • Sponsor Opportunities
  • Patients Rising
  • Patient Action Center
  • Facebook
  • Twitter
  • Instagram
All rights reserved. © 2023 Patients Rising Now